Possible adverse effects of dpp 4 inhibitors in type 2 diabetes

Possible adverse effects of dpp 4 inhibitors in type 2 diabetes

What are incretins and incretinomimetics, which drugs from the group of dipeptidyl peptidase 4 inhibitors and glucagon-like peptide 1 agonists are used in the treatment of diabetes? Today you will learn what these long and complex words mean, and most importantly, how to apply this knowledge. This article will focus on completely new drugs-analogs of …

Possible adverse effects of dpp 4 inhibitors in type 2 diabetes Read More »